journal article·2022-11-05Open access

A Novel Hybrid Membrane for Urinary Conduit Substitutes Based on Small Intestinal Submucosa Coupled with Two Synthetic Polymers

Martina Casarin, Martina Todesco, Deborah Sandrin, Filippo Romanato, Andrea Bagno, Alessandro Morlacco, Fabrizio Dal Moro

Abstract

Among the urinary tract’s malignancies, bladder cancer is the most frequent one: it is at the tenth position of most common cancers worldwide. Currently, the gold standard therapy consists of radical cystectomy, which results in the need to create a urinary diversion using a bowel segment from the patient. Nevertheless, due to several complications associated with bowel resection and anastomosis, which significantly affect patient quality of life, it is becoming extremely important to find an alternative solution. In our recent work, we proposed the decellularized porcine small intestinal submucosa (SIS) as a candidate material for urinary conduit substitution. In the present study, we create SIS-based hybrid membranes that are obtained by coupling decellularized SIS with two commercially available polycarbonate urethanes (Chronoflex AR and Chronoflex AR-LT) to improve SIS mechanical resistance and impermeability. We evaluated the hybrid membranes by means of immunofluorescence, two-photon microscopy, FTIR analysis, and mechanical and cytocompatibility tests. The realization of hybrid membranes did not deteriorate SIS composition, but the presence of polymers ameliorates the mechanical behavior of the hybrid constructs. Moreover, the cytocompatibility tests demonstrated a significant increase in cell growth compared to decellularized SIS alone. In light of the present results, the hybrid membrane-based urinary conduit can be a suitable candidate to realize a urinary diversion in place of an autologous intestinal segment. Further efforts will be performed in order to create a cylindrical-shaped hybrid membrane and to study its hydraulic behavior.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Historical Education Studies Worldwide · Historical Architecture and Urbanism · Architecture, Design, and Social History

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Surgery, Oncology and Gastroenterology, Giustiniani 2, 35128 Padua, Italy

L.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region, Via N. Giustiniani 2, 35128 Padua, Italy

Department of Industrial Engineering, University of Padua, Via Marzolo 9, 35131 Padua, Italy

Department of Physics and Astronomy ‘G. Galilei’, University of Padova, Via Marzolo 8, 35131 Padua, Italy

Laboratory of Optics and Bioimaging, Institute of Pediatric Research Città della Speranza, 35127 Padua, Italy

Funding

LifeLab Program of the Consorzio per la Ricerca Sanitaria (CORIS) of the Veneto Region, Italy

References (75)

Show source-provided references
1. Cancer statistics, 202210.3322/caac.21708 ↗
2. Dobruch, J., and Oszczudłowski, M. (2021). Bladder Cancer: Current Challenges and Future Directions. Med. Lith., 57.10.3390/medicina57080749 ↗
3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA10.3322/caac.21660 ↗
4. New Roadmaps for Non-Muscle-Invasive Bladder Cancer With Unfavorable Prognosis10.3389/fchem.2020.00600 ↗
5. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology10.1016/j.eururo.2008.07.031 ↗
6. Fast Track Program in Patients Undergoing Radical Cystectomy: Results in 362 Consecutive Patients10.1016/j.jamcollsurg.2009.09.026 ↗
7. Definition, Incidence, Risk Factors, and Prevention of Paralytic Ileus Following Radical Cystectomy: A Systematic Review10.1016/j.eururo.2012.11.051 ↗
8. Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol10.1016/j.euf.2017.04.003 ↗
9. Postoperative Management of Radical Cystectomy. Review of the Evidence on the Prevention and Treatment of Urological Complications10.1016/j.acuro.2017.04.006 ↗
10. Long Term Complications after Radical Cystoprostatectomy with Orthotopic Diversion in Male Patients: Preliminary Experience10.1016/j.afju.2013.02.008 ↗
11. Concise Review: Tissue Engineering of Urinary Bladder; We Still Have a Long Way to Go?10.1002/sctm.17-0101 ↗
12. Design, Fabrication, and Preparation of Synthetic Scaffolds for Urologic Tissue Engineering10.1007/978-1-62703-363-3_14 ↗
13. Characterization of a PGA-Based Scaffold for Use in a Tissue-Engineered Neo-Urinary Conduit10.1007/978-1-62703-363-3_15 ↗
14. Electrospun PLGA and PLGA/Gelatin Scaffolds for Tubularized Urethral Replacement: Studies in Vitro and in Vivo10.1177/08853282211030904 ↗
15. Tissue-Engineered Urinary Bladder Wall Using PLGA Mesh-Collagen Hybrid Scaffolds: A Comparison Study of Collagen Sponge and Gel as a Scaffold10.1016/j.jpedsurg.2003.08.034 ↗
16. Tissue-Engineered Autologous Bladders for Patients Needing Cystoplasty10.1016/S0140-6736(06)68438-9 ↗
17. Silk Fibroin Scaffolds for Urologic Tissue Engineering10.1007/s11934-015-0567-x ↗
18. Aligned Silk Sponge Fabrication and Perfusion Culture for Scalable Proximal Tubule Tissue Engineering10.1021/acsami.1c00548 ↗
19. Development of a Porcine Bladder Acellular Matrix with Well-Preserved Extracellular Bioactive Factors for Tissue Engineering10.1089/ten.tec.2009.0311 ↗
20. Tubular Constructs as Artificial Urinary Conduits10.1016/j.juro.2016.04.092 ↗
21. A Preclinical Study of Cell-Seeded Tubularized Scaffolds Specially Secreting LL37 for Reconstruction of Long Urethral Defects
22. Characterizing the Inherent Activity of Urinary Bladder Matrix for Adhesion, Migration, and Activation of Fibroblasts as Compared with Collagen-Based Synthetic Scaffold
23. Collagen Cell Carriers Seeded with Human Urothelial Cells for Urethral Reconstructive Surgery: First Results in a Xenograft Minipig Model10.1007/s00345-016-1959-3 ↗
24. Biodegradable Materials for Bone Repair and Tissue Engineering Applications10.3390/ma8095273 ↗
25. Porcine Small Intestinal Submucosa Mesh for Treatment of Pelvic Organ Prolapsed10.4103/0366-6999.192784 ↗
26. Immunomodulatory Response of Layered Small Intestinal Submucosa in a Rat Bladder Regeneration Model10.1002/jbm.b.34289 ↗
27. Urethral Reconstruction with Autologous Urine-Derived Stem Cells Seeded in Three-Dimensional Porous Small Intestinal Submucosa in a Rabbit Model10.1186/s13287-017-0500-y ↗
28. Reduced Urothelial Regeneration in Rat Bladders Augmented with Permeable Porcine Small Intestinal Submucosa Assessed by Magnetic Resonance Imaging10.1002/jbm.b.33985 ↗
29. Procyanidins-Crosslinked Small Intestine Submucosa: A Bladder Patch Promotes Smooth Muscle Regeneration and Bladder Function Restoration in a Rabbit Model
30. The Effects of Bone Marrow Stem and Progenitor Cell Seeding on Urinary Bladder Tissue Regeneration10.1038/s41598-021-81939-5 ↗
31. An Extracellular Matrix-Mimicking, Bilayered, Heterogeneous, Porous, Nanofibrous Scaffold for Anterior Urethroplasty in a Rabbit Model10.1088/1748-605X/ab9fd0 ↗
32. Casarin, M., Fortunato, T.M., Imran, S., Todesco, M., Sandrin, D., Borile, G., Toniolo, I., Marchesan, M., Gerosa, G., and Bagno, A. (2022). Porcine Small Intestinal Submucosa (SIS) as a Suitable Scaffold for the Creation of a Tissue-Engineered Urinary Conduit: Decellularization, Biomechanical and Biocompatibility Characterization Using New Approaches. Int. J. Mol. Sci., 23.10.3390/ijms23052826 ↗
33. Urinary Bladder Augmentation with Acellular Biologic Scaffold-A Preclinical Study in a Large Animal Model10.1002/jbm.b.34920 ↗
34. Angiogenesis Potential of Bladder Acellular Matrix Hydrogel by Compounding Endothelial Cells10.1021/acsabm.8b00760 ↗
35. Use of Human Amniotic Membrane Repair of Anterior Urethral Defect: First Clinical Report
36. Urethral Tissue Reconstruction Using the Acellular Dermal Matrix Patch Modified with Collagen-Binding VEGF in Beagle Urethral Injury Models10.1155/2021/5502740 ↗
37. The Potential Role of Tissue-Engineered Urethral Substitution: Clinical and Preclinical Studies10.1002/term.2112 ↗
38. Hybrid Membranes for the Production of Blood Contacting Surfaces: Physicochemical, Structural and Biomechanical Characterization10.1186/s40824-021-00227-5 ↗
39. A Solution Grade Biostable Polyurethane Elastomer: ChronoFlex® AR10.1177/088532829400800303 ↗
40. Small Intestinal Submucosa as a Large Diameter Vascular Graft in the Dog10.1016/0022-4804(89)90050-4 ↗
41. Small Intestinal Submucosa as a Small-Diameter Arterial Graft in the Dog10.3109/08941939009140351 ↗
42. Borile, G., Sandrin, D., Filippi, A., Anderson, K.I., and Romanato, F. (2021). Label-Free Multiphoton Microscopy: Much More Than Fancy Images. Int. J. Mol. Sci., 22.10.3390/ijms22052657 ↗
43. Multimodal Label-Free Ex Vivo Imaging Using a Dual-Wavelength Microscope with Axial Chromatic Aberration Compensation
44. Fiji: An Open-Source Platform for Biological-Image Analysis10.1038/nmeth.2019 ↗
45. Experimental Investigation of Collagen Waviness and Orientation in the Arterial Adventitia Using Confocal Laser Scanning Microscopy10.1007/s10237-011-0325-z ↗
46. Zouhair, S., Sasso, E.D., Tuladhar, S.R., Fidalgo, C., Vedovelli, L., Filippi, A., Borile, G., Bagno, A., Marchesan, M., and De Rossi, G. (2020). A Comprehensive Comparison of Bovine and Porcine Decellularized Pericardia: New Insights for Surgical Applications. Biomolecules, 10.10.3390/biom10030371 ↗
47. Oldenburg, K. (2022, February 11). LoadSpectra. Available online: https://www.mathworks.com/matlabcentral/fileexchange/57904-loadspectra.
48. Council of Europe (2005). European Pharmacopoeia, Council of Europe. 2.6.1. Sterility.
49. C.S.A (2009). ISO 10993-5 in Vitro Cytotoxicity. Int. Organ., 2007, 1–11.
50. Urinary Diversion after Radical Cystectomy for Bladder Cancer: Options, Patient Selection, and Outcomes: Urinary Diversion after Radical Cystectomy for Bladder Cancer10.1111/bju.12121 ↗
51. Late Complications of Robot-Assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion10.1007/s00345-020-03378-7 ↗
52. Tissue Engineering and Conduit Substitution10.1016/j.ucl.2017.09.014 ↗
53. Regenerative and Engineered Options for Urethroplasty10.1038/s41585-019-0198-y ↗
54. Casarin, M., Morlacco, A., and Dal Moro, F. (2021). Bladder Substitution: The Role of Tissue Engineering and Biomaterials. Processes, 9.10.3390/pr9091643 ↗
55. Composite Scaffolds for the Engineering of Hollow Organs and Tissues10.1016/j.ymeth.2008.10.014 ↗
56. A Poly (Lactic Acid-Co-Caprolactone)–Collagen Hybrid for Tissue Engineering Applications10.1089/ten.tea.2008.0194 ↗
57. A Collagen-Poly(Lactic Acid-Co-ε-Caprolactone) Hybrid Scaffold for Bladder Tissue Regeneration10.1016/j.biomaterials.2011.02.012 ↗
58. Franck, D., Gil, E.S., Adam, R.M., Kaplan, D.L., Chung, Y.G., Estrada, C.R., and Mauney, J.R. (2013). Evaluation of Silk Biomaterials in Combination with Extracellular Matrix Coatings for Bladder Tissue Engineering with Primary and Pluripotent Cells. PLoS ONE, 8.10.1371/journal.pone.0056237 ↗
59. A Bilayered Hybrid Microfibrous PLGA-Acellular Matrix Scaffold for Hollow Organ Tissue Engineering10.1016/j.biomaterials.2012.10.075 ↗
60. Increased Porosity of Electrospun Hybrid Scaffolds Improved Bladder Tissue Regeneration10.1002/jbm.a.34889 ↗
61. Constructs of Electrospun PLGA, Compressed Collagen and Minced Urothelium for Minimally Manipulated Autologous Bladder Tissue Expansion10.1016/j.biomaterials.2014.04.002 ↗
62. Adamowicz, J., Pokrywczyńska, M., Tworkiewicz, J., Kowalczyk, T., Van Breda, S.V., Tyloch, D., Kloskowski, T., Bodnar, M., Skopinska-Wisniewska, J., and Marszałek, A. (2016). New Amniotic Membrane Based Biocomposite for Future Application in Reconstructive Urology. PLoS ONE, 11.10.1371/journal.pone.0146012 ↗
63. Polyesterurethane and Acellular Matrix Based Hybrid Biomaterial for Bladder Engineering10.1002/jbm.b.33591 ↗
64. Development of a Conductive Biocomposite Combining Graphene and Amniotic Membrane for Replacement of the Neuronal Network of Tissue-Engineered Urinary Bladder10.1038/s41598-020-62197-3 ↗
65. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering10.1016/j.biomaterials.2010.10.006 ↗
66. The development of marine biomaterial derived from decellularized squid mantle for potential application as tissue engineered urinary conduit10.1016/j.msec.2020.111579 ↗
67. European Chemicals Agency (2012). Inclusion of Substances of Very High Concerns in the Candidate List, European Chemicals Agency.
68. A tissue-engineered urinary conduit in a porcine urinary diversion model10.1038/s41598-021-94613-7 ↗
69. Tissue engineering for the oncologic urinary bladder10.1038/nrurol.2012.158 ↗
70. Constructing artificial urinary conduits: Current capabilities and future potential10.1080/17434440.2019.1562901 ↗
71. Differentiation of human bone marrow mesenchymal stem cells into bladder cells: Potential for urological tissue engineering10.1089/ten.tea.2009.0625 ↗
72. C53 Hair Follicle Stem Cells and Bone Marrow Mesenchymal Stem Cells in Bladder Regeneration10.1016/S1569-9056(10)61577-1 ↗
73. Bone marrow mesenchymal stem cells differentiate into urothelial cells and the implications for reconstructing urinary bladder mucosa10.1007/s10616-011-9376-3 ↗
74. Tissue engineering and ureter regeneration: Is it possible?10.5301/ijao.5000130 ↗
75. The Artificial Conduit for Urinary Diversion in Rats: A Preliminary Study10.1016/j.transproceed.2007.02.092 ↗